Debate of the Decade: RCTs in the Era of Precision Oncology
How do you design clinical trials in the era of precision oncology? Are prospective randomized controlled trials necessary anymore? Drs. Ray Kurzrock, Vivek Subbiah, and Christopher Booth join Dr. Chadi Nabhan to answer these important questions.
Increased Psychiatric Burden in Patients with Juvenile Idiopathic Arthritis
Coronary Artery Calcium Score of More Than 300 is Equivalent to Established Atherosclerotic Vascular Diseases
Cost Hampers Sacituzumab Despite Meaningful Advantage